Dean Follmann

42PUBLICATIONS
156CO-AUTHORS
Nanotoxicology, health and safetyMolecular targetsMedical molecular engineering of nucleic acids and proteinsInnate immunityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (42)

|Nov 25, 2025
A Test-Negative Design for Immune Correlates Approximates a Traditional Exposure-Proximal Design but Requires Far Fewer Blood Samples.

Dean Follmann, Lauren Dang, Eric Chu

|Oct 14, 2025
A SARS-CoV-2 variant‑adjusted threshold of protection model for monoclonal antibody pre-exposure prophylaxis against COVID-19.

Rhiannon Edge, Sam Matthews, Bahar Ahani

|Jun 22, 2025
A surrogate endpoint-based provisional approval causal roadmap, illustrated by vaccine development.

Peter B Gilbert, James Peng, Larry Han

|Jan 17, 2025
Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost.

Bo Zhang, Youyi Fong, Lauren Dang

|Dec 24, 2024
Vector-Induced Humoral Responses After rVSVΔG-ZEBOV-GP Immunization Identify Vaccinated Individuals and Correlate With Ebola Virus Glycoprotein Antibodies.

Prabha Chandrasekaran, Irina Maljkovic Berry, Viviane Callier

|Dec 16, 2024
Who to Boost When: The Effect of Age and Dosing Interval on Delta and Omicron COVID-19 Incidence in the Open-label Phase of the COVE Trial.

Dean Follmann, Xiaowei Wang, Lindsey R Baden

Pageof 7

Frequent Collaborators

15 joint publications

Peter Gilbert

13 joint publications

Lawrence Corey

12 joint publications

David Benkeser

11 joint publications

Lindsay N Carpp